<DOC>
	<DOCNO>NCT02321527</DOCNO>
	<brief_summary>The goal clinical research learn ultrasound contrast agent call OPTISON ( perflutren protein type A ) effective find sentinel lymph node surgery . Contrast agent help make ultrasound image accurate . The sentinel lymph node first node may target cancer cell spread tumor .</brief_summary>
	<brief_title>Feasibility Ultrasound Microbubble Contrast-Enhanced ( CEUS ) Sentinel Lymph Node Imaging With Guided Biopsy Breast Cancer Patients</brief_title>
	<detailed_description>Study Procedures : If agree eligible take part , receive perflutren protein type A injection skin near nipple . After receive injection , radiologist take ultrasound image videos tumor lymph node underarm area . You biopsy sentinel lymph node identify ultrasound titanium clip marker insert node . The clip help distinguish biopsied node node . You tell result biopsy . After biopsy , radioactive seed may insert node allow surgeon find remove surgery , extra node may remove time . You still standard care sentinel lymph node biopsy already schedule surgery . You sign separate surgical consent form explain procedure risk . You call phone 30 day seed remove check side effect . This phone call take 10 minute . Length Study : Your active participation study follow phone call . This investigational study . Perflutren protein type A FDA approve commercially available use contrast-enhanced echocardiogram . Its use study investigational . Up 21 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . 18 year old . 2 . Ipsilateral biopsyproven invasive breast cancer &lt; 5 cm maximal dimension Ultrasound Mammography . 3 . No abnormal axillary node identify grayscale AUS , abnormal node benign subsequent FNA biopsy . 1 . Pregnant nursing woman 2 . Prior SLN dissection 3 . Neoadjuvant chemotherapy . 4 . Prior axillary lymph node surgery . 5 . Prior history ipsilateral breast cancer . 6 . Known suspected : Cardiac shunt 7 . Known suspected : hypersensitivity perflutren , blood , blood product albumin 8 . Known suspected : hypersensitivity prior OPTISON administration</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Microbubble contrast-enhanced ultrasound</keyword>
	<keyword>CEUS</keyword>
	<keyword>Sentinel lymph node</keyword>
	<keyword>SLN</keyword>
	<keyword>Perflutren Protein-Type A Microspheres Injectable Suspension</keyword>
	<keyword>OPTISONâ„¢</keyword>
	<keyword>Ultrasound</keyword>
	<keyword>Breast biopsy</keyword>
	<keyword>Radioactive seed</keyword>
	<keyword>Phone call</keyword>
	<keyword>Fine needle aspiration</keyword>
	<keyword>FNA</keyword>
</DOC>